Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by everswannon Feb 07, 2008 7:49am
138 Views
Post# 14330820

Cascade effect of Tesamorelin

Cascade effect of TesamorelinBy regulating the Growth hormone production system, Tesamorelin seems to have a cascade effect downward. Reduce lipid (fat) accumulation and in undesirable location, basically putting back the body as where it should be. Naturally, tryglycirite level down in blood (this is basically fat in the blood). Going down further; cardiac marker and insulin resistance level The effect of tesamorelin points to one trend; general improvement by correcting all adverse effects related to fat accumulation. Cause of fat accumulation can be multiple, Tesamorelin could be an answer for multiple application. Will take longer to proof Cascade effect; cardiac market and insulin could take longer to manifest in data points. This is science in the making! Very promising results, this should trigger scientific curiousity and appraisal! Anti-obecity application seems more real than ever. What a drug! Cascade effect.
Bullboard Posts